Cambridge Heart expands St Jude deal:
This article was originally published in Clinica
Executive Summary
Cambridge Heart and St Jude Medical are to sell the former's HearTwave II Microvolt T-Wave Alternans test to all North American markets, following an amendment to a previous co-marketing agreement. Under the terms of the original deal, signed in March, Cambridge Heart was to target only the internal medicine and primary care markets, while St Jude would address the cardiology and electrophysiology markets. Cambridge Heart said the amendment will not have an impact on its revenue guidance for 2007.